Studies have revealed that metabolic reprogramming, mediated by key metabolic enzymes (including mTOR, HIF-1, and AMPK) and pathways (such as glycolysis and lipid metabolism), acts as a major regulator of Th17/Treg differentiation and function owing to their distinct metabolic profiles
Changing the diagnostic label from NAFLD (ICD-10 K76.0) to MASLD (ICD-10 K76.0, same code) does not change formulary policy
Results Search Results and Study Characteristics The search identified a broad and heterogeneous body of literature spanning multiple peptide agents and a wide range of non-orthopaedic indications
Freund P, Wheeler-Kingshott CA, Nagy Z, Gorgoraptis N, Weiskopf N, Friston K, et al
Zeng Q, Li P, Wu H, Zhuang Y, Zhang Y, Asemani S, et al